On August 6, 2020, U.S. President Donald Trump issued an Executive Order whose expressed goal is bolstering domestic supply chains and reducing reliance on foreign manufacturers for Essential Medicines, Medical Countermeasures, and other Critical Inputs needed to make essential medicines.1 The Order also seeks to combat counterfeit Essential Medicines and Medical Countermeasures.
The Order states that “[i]t is critical that we reduce our dependence on foreign manufacturers …[,] ensure sufficient and reliable long-term domestic production of these products [and] … minimize potential shortages” in light of the threats posed by public health emergencies, such as the current COVID-19 pandemic.
Sidley Austin LLP provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship.
Attorney Advertising - For purposes of compliance with New York State Bar rules, our headquarters are Sidley Austin LLP, 787 Seventh Avenue, New York, NY 10019, 212.839.5300; One South Dearborn, Chicago, IL 60603, 312.853.7000; and 1501 K Street, N.W., Washington, D.C. 20005, 202.736.8000.